Document Actions

You are here: Home Faculty Professors Kern

Kern

Prof. Dr.
Winfried Kern

Department of Medicine II
Phone: 0049-761-27018190

www.uniklinik-freiburg.de/infektiologie

CV

  • Medical studies in Bordeaux, Erlangen, Heidelberg
  • Residency/fellowships in internal medicine, infectious diseases and tropical medicine, hematology-oncology, rheumatology/clinical immunology in Heidelberg, Ulm, Tübingen, Providence (RI/USA) und San Francisco (CA/USA
  • 1994 Habilitation, Internal Medicine, University of Ulm
  • Since 2002 Professor (C3) of Internal Medicine and Infectious Diseases at the Medical Center – University of Freiburg and Head of the Division of Infectious Diseases

Selected publications

  • Schuster S, Kohler S, Buck A, Dambacher C, König A, Bohnert JA, Kern WV. Random mutagenesis of the multidrug transporter AcrB from Escherichia coli for identification of putative target residues of efflux pump inhibitors. Antimicrob Agents Chemother. 2014 Nov; 58(11):6870-8.
  • Rieg S, Jonas D, Kaasch AJ, Porzelius C, Peyerl-Hoffmann G, Theilacker C, Küpper MF, Schneider C, Seifert H, Kern WV. Microarraybased genotyping and clinical outcomes of Staphylococcus aureus bloodstream infection: an exploratory study. PLoS One. 2013; 8(8):e71259.
  • Bohnert JA, Kern WV. Selected arylpiperazines are capable of reversing multidrug resistance in Escherichia coli overexpressing RND efflux pumps. Antimicrob Agents Chemother. 2005; 49(2):849-52.
  • Kern WV, Oethinger M, Jellen-Ritter AS, Levy B. Non-target gene mutations in the development of fluoroquinolone resistance in Escherichia coli. Antimicrob Agents Chemother. 2000; 44(4):814-20.
  • Kern WV, Cometta A, De Bock R, Langenaeken J, Paesmans M, Gaya H. Oral versus intravenous empirical antimicrobial therapy for fever in patients with granulocytopenia who are receiving cancer chemotherapy. International Antimicrobial Therapy Cooperative Group of the EORTC. N Engl J Med. 1999; 341(5):312-8.